logo

VetSRev

Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review

Faridnia, R. and Daryani, A. and Sarvi, S. and Sharif, M. and Kalani, H.

Comp Immunol Microbiol Infect Dis (2018) 59: 32–40

DOI: 10.1016/j.cimid.2018.09.005

Abstract

Toxoplasma gondii is an obligate intracellular parasitic protozoan that infects a wide variety of vertebrates as intermediate hosts. The aim of the current systematic review study is to clarify the latest status of studies in the literature regarding rhoptry-associated recombinant proteins or rhoptry-associated recombinant DNAs as potential vaccines against toxoplasmosis. The search was performed systematically in 8 databases, four in English and four in Persian, up to February 2017. Overall, ROP2 was the most commonly used ROPs in DNA vaccines (27.27%) and protein vaccines (6.81%). Furthermore, regarding the type of adjuvants, route and dose of vaccination, animal models, challenge methods, and measurement of immune responses has been discussed in the text. It is hoped that this article help researchers to conduct more effective studies in the field of immunization against T. gondii.

Citation

Faridnia, R., Daryani, A., Sarvi, S., Sharif, M., & Kalani, H. (2018). Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review. Comp Immunol Microbiol Infect Dis, 59, 32–40. https://doi.org/10.1016/j.cimid.2018.09.005 Animals, Humans, Protozoan Vaccines/immunology, Vaccination, Toxoplasma gondii, Recombinant Proteins/immunology, Antibodies, Protozoan/immunology, Toxoplasma/*immunology, Antigens, Protozoan/*immunology, Immunization/methods, Protozoan Proteins/immunology, Rhoptry DNA, Rhoptry protein, Toxoplasmosis, Animal/*immunology, Vaccination/methods, Vaccines, DNA/immunology

Keywords